XENETIC BIOSCIENCES, INC. Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost
XENETIC BIOSCIENCES, INC. (XBIO) reported Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost of $25.01 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost · last filed 2016-03-30
- XENETIC BIOSCIENCES, INC. share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost for fiscal 2015 was $25.01K.
| Period end | Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost 12 month |
|---|---|
| 2015-12-31 | $25.01K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |